For US residents only.

YOUR TREATMENT JOURNEY

AFINITOR can treat people with advanced renal cell carcinoma when sunitinib or sorafenib have not worked.

Important Safety Information:

Patients should not take AFINITOR® (everolimus) Tablets if they are allergic to AFINITOR or to any of its ingredients. Patients should tell their health care provider before taking AFINITOR if they are...

See More
Approved Use:

AFINITOR® (everolimus) Tablets is a prescription medicine used to treat adults with advanced kidney cancer (renal cell carcinoma or RCC) when certain other medicines (ie, Sutent® [sunitinib] or Nexavar® [sorafenib]) have not worked.

learn more about

AFINITOR

AFINITOR® (everolimus) Tablets is a prescription medicine used to treat adults with advanced kidney cancer (renal cell carcinoma or RCC) when certain other medicines (ie, Sutent® [sunitinib] or Nexavar® [sorafenib]) have not worked.

Learn More
learn more about

ADVANCED RENAL CELL CARCINOMA

Renal cell carcinoma (RCC) is the most common type of kidney cancer. Advanced RCC is when the cancer has spread to other places in the body. In order to understand the causes of advanced kidney cancer, it may be helpful to understand the role of your kidneys.

Learn More